NAMI Pharma Marketing Blog Grassley
View PDF of blog article here
Similar Posts
Top SFBC officials Quit Amid Senate Inquiry Clinical Trials_ Bloomberg News
In its continuing coverage of corrupt clinical drug trial practices, Bloomberg News reports that all three founders of SFBC International, one of the largest clinical trial business operations that had failed to even screen human subjects for turberculosis, and threatened others with deportation if they refused to become guinea pigs, quit after the Senate Finance committee began investigating drug trial safety issues:
Jane Pauley- from Steroids to mania to depression to Bi-Polar-to Drugs for Life
"After another four months or so on antidepressants, bringing me to a total of 10 months between the steroids and antidepressants, I was suddenly flipped into this hypomania."
FDA acknowledges failure to act as defibrillator malfunction increased
FDA acknowledges failure to act as defibrillator malfunction increased: 4,225 failed between 2000–2003 Sat, 17 Sep 2005 The Washington Post reports that the number of failed heart defibrillators is increasing: “William H. Maisel, the Harvard Medical School physician who conducted the FDA study, said the increase is significant and contrasts…
House Votes to Prevent Pharma-tied Scientists on FDA Advisory Panels
House Votes to Prevent Pharma-tied Scientists on FDA Advisory Panels Thu, 9 Jun 2005 The House passed an amendment introduced by Congressman Maurice Hinchey (NY) to rein in pharmaceutical industry influence on FDA advisory panels whose recdommendations have resulted in the approval of lethal drugs. Below Merrill Goozner write: “The…
Latest Report Blasts FDA Bungling Drug Safety Tracking–Waste & 4-year Delay
FDA administrators "mishandled the initiative through bureaucratic infighting, flawed planning and duplicative work performed by outside contractors." The report estimates that agency administrators wasted $25 million on a computer system that won't be functional before 2009.
Intimidation, Politics and Drug Industry Cripple U.S. Medicine – FDA Permits Dr. David Graham to publish Vioxx Report
Intimidation, Politics and Drug Industry Cripple U.S. Medicine – FDA Permits Dr. David Graham to publish Vioxx Report Wed, 5 Jan 2005 FDA officials could not maintain their iron grip in an effort to suppress evidence of far reaching lethal effects of Vioxx when their actions were in full public…